The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression - PubMed

Affiliations

• PMID: 17934516
• DOI: 10.1038/sj.onc.1210855

The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression

M Achour et al. Oncogene. 2008.

Abstract

Inverted CCAAT box-binding protein of 90 kDa (ICBP90) is over-expressed in several types of cancer, including breast, prostate and lung cancers. In search for proteins that interact with the set and ring-associated (SRA) domain of ICBP90, we used the two-hybrid system and screened a placental cDNA library. Several clones coding for a new domain of DNMT1 were found. The interaction, between the ICBP90 SRA domain and the DNMT1 domain, has been confirmed with purified proteins by glutathione-S-transferase pull-down experiments. We checked whether ICBP90 and DNMT1 are present in the same macro-molecular complexes in Jurkat cells and immortalized human vascular smooth muscle cells (HVTs-SM1). Co-immunoprecipitation experiments showed that ICBP90 and DNMT1 are present in the same molecular complex, which was further confirmed by co-localization experiments as assessed by immunocytochemistry. Downregulation of ICBP90 and DNMT1 decreased VEGF gene expression, a major pro-angiogenic factor, whereas those of p16(INK4A) gene and RB1 gene were significantly enhanced. Together, these results indicate that DNMT1 and ICBP90 are involved in VEGF gene expression, possibly via an interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 and an upregulation of p16(INK4A). They further suggest a new role of ICBP90 in the relationship between histone ubiquitination and DNA methylation in the context of tumoral angiogenesis and tumour suppressor genes silencing.

Similar articles

• Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1.

  Achour M, Mousli M, Alhosin M, Ibrahim A, Peluso J, Muller CD, Schini-Kerth VB, Hamiche A, Dhe-Paganon S, Bronner C. Achour M, et al. Biochem Biophys Res Commun. 2013 Jan 4;430(1):208-12. doi: 10.1016/j.bbrc.2012.11.087. Epub 2012 Nov 28. Biochem Biophys Res Commun. 2013. PMID: 23201574

• ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.

  Unoki M, Nishidate T, Nakamura Y. Unoki M, et al. Oncogene. 2004 Oct 7;23(46):7601-10. doi: 10.1038/sj.onc.1208053. Oncogene. 2004. PMID: 15361834

• UHRF1 plays a role in maintaining DNA methylation in mammalian cells.

  Bostick M, Kim JK, Estève PO, Clark A, Pradhan S, Jacobsen SE. Bostick M, et al. Science. 2007 Sep 21;317(5845):1760-4. doi: 10.1126/science.1147939. Epub 2007 Aug 2. Science. 2007. PMID: 17673620

• Recruitment of Dnmt1 roles of the SRA protein Np95 (Uhrf1) and other factors.

  Sharif J, Koseki H. Sharif J, et al. Prog Mol Biol Transl Sci. 2011;101:289-310. doi: 10.1016/B978-0-12-387685-0.00008-1. Prog Mol Biol Transl Sci. 2011. PMID: 21507355 Review.

• Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

  Alhosin M, Sharif T, Mousli M, Etienne-Selloum N, Fuhrmann G, Schini-Kerth VB, Bronner C. Alhosin M, et al. J Exp Clin Cancer Res. 2011 Apr 15;30(1):41. doi: 10.1186/1756-9966-30-41. J Exp Clin Cancer Res. 2011. PMID: 21496237 Free PMC article. Review.

Cited by

• Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway.

  Alhosin M, León-González AJ, Dandache I, Lelay A, Rashid SK, Kevers C, Pincemail J, Fornecker LM, Mauvieux L, Herbrecht R, Schini-Kerth VB. Alhosin M, et al. Sci Rep. 2015 Mar 11;5:8996. doi: 10.1038/srep08996. Sci Rep. 2015. PMID: 25757575 Free PMC article.

• Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas.

  Pita JM, Banito A, Cavaco BM, Leite V. Pita JM, et al. Br J Cancer. 2009 Nov 17;101(10):1782-91. doi: 10.1038/sj.bjc.6605340. Epub 2009 Oct 6. Br J Cancer. 2009. PMID: 19809427 Free PMC article.

• Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein.

  Nady N, Lemak A, Walker JR, Avvakumov GV, Kareta MS, Achour M, Xue S, Duan S, Allali-Hassani A, Zuo X, Wang YX, Bronner C, Chédin F, Arrowsmith CH, Dhe-Paganon S. Nady N, et al. J Biol Chem. 2011 Jul 8;286(27):24300-11. doi: 10.1074/jbc.M111.234104. Epub 2011 Apr 13. J Biol Chem. 2011. PMID: 21489993 Free PMC article.

• UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells.

  Kim JK, Estève PO, Jacobsen SE, Pradhan S. Kim JK, et al. Nucleic Acids Res. 2009 Feb;37(2):493-505. doi: 10.1093/nar/gkn961. Epub 2008 Dec 4. Nucleic Acids Res. 2009. PMID: 19056828 Free PMC article.

• Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain.

  Frauer C, Hoffmann T, Bultmann S, Casa V, Cardoso MC, Antes I, Leonhardt H. Frauer C, et al. PLoS One. 2011;6(6):e21306. doi: 10.1371/journal.pone.0021306. Epub 2011 Jun 22. PLoS One. 2011. PMID: 21731699 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • IMEx Consortium

• Miscellaneous

  • NCI CPTAC Assay Portal